238 related articles for article (PubMed ID: 23629476)
21. Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients.
Tepper R; Beyth Y; Altaras MM; Zalel Y; Shapira J; Cordoba M; Cohen I
Gynecol Oncol; 1997 Mar; 64(3):386-91. PubMed ID: 9062139
[TBL] [Abstract][Full Text] [Related]
22. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W
Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080
[TBL] [Abstract][Full Text] [Related]
23. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen.
Lee M; Piao J; Jeon MJ
Yonsei Med J; 2020 Apr; 61(4):317-322. PubMed ID: 32233174
[TBL] [Abstract][Full Text] [Related]
24. The value of transvaginal ultrasonography in the prediction of endometrial pathologies in asymptomatic postmenopausal breast cancer tamoxifen-treated patients.
Markovitch O; Tepper R; Fishman A; Shapira J; Aviram R; Cohen I
Gynecol Oncol; 2004 Dec; 95(3):456-62. PubMed ID: 15581946
[TBL] [Abstract][Full Text] [Related]
25. The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Coibion M; Bianco AR;
Hum Reprod; 2005 Jan; 20(1):294-301. PubMed ID: 15513977
[TBL] [Abstract][Full Text] [Related]
26. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
[TBL] [Abstract][Full Text] [Related]
27. Sonographic, hysteroscopic, and histologic evaluation of the endometrium in postmenopausal women with breast cancer receiving tamoxifen.
Ceci O; Bettocchi S; Marello F; Nappi L; Chiechi LM; Laricchia L; Masciandaro A
J Am Assoc Gynecol Laparosc; 2000 Feb; 7(1):77-81. PubMed ID: 10648743
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of endometrial changes and p53 expression in tamoxifen treated women: comparison of various methods.
Pokharel HP; Bhatla N; Kriplani A; Mukhopadhyay A; Srivastava A; Ralhan R
Kathmandu Univ Med J (KUMJ); 2006; 4(2):145-51. PubMed ID: 18603889
[TBL] [Abstract][Full Text] [Related]
29. Uterine pathologies in patients undergoing tamoxifen therapy for breast cancer: ultrasonographic, hysteroscopic and histological findings.
Le Donne M; Lentini M; De Meo L; Benedetto V; Mesiti M
Eur J Gynaecol Oncol; 2005; 26(6):623-6. PubMed ID: 16398223
[TBL] [Abstract][Full Text] [Related]
30. Transvaginal US and hysterosonography in postmenopausal women with breast cancer receiving tamoxifen: correlation with hysteroscopy and pathologic study.
Fong K; Causer P; Atri M; Lytwyn A; Kung R
Radiographics; 2003; 23(1):137-50; discussion 151-5. PubMed ID: 12533649
[TBL] [Abstract][Full Text] [Related]
31. [Ultrasound endometrium follow-up during tamoxifen treatment: Really not reliable or useful after all?].
Burkart C; Wight E; Pók J; Kernen B; Traber M; Haller U; Bajka M
Ultraschall Med; 2001 Jun; 22(3):136-42. PubMed ID: 11484445
[TBL] [Abstract][Full Text] [Related]
32. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.
Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S
Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913
[TBL] [Abstract][Full Text] [Related]
33. Ultrasound, hysteroscopy and endometrial biopsy in the investigation of endometrial cancer.
Symonds I
Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):381-91. PubMed ID: 11476560
[TBL] [Abstract][Full Text] [Related]
34. Effect of tamoxifen on postmenopausal endometrium.
Kalampokas T; Sofoudis C; Anastasopoulos C; Boutas I; Melloy S; Kondi-Pafiti A; Kalampokas E; Botsis D; Salakos N
Eur J Gynaecol Oncol; 2013; 34(4):325-8. PubMed ID: 24020139
[TBL] [Abstract][Full Text] [Related]
35. Postmenopausal endometrial pathologies with tamoxifen treatment: comparison between hysteroscopic and hysterectomy findings.
Cohen I; Azaria R; Aviram R; Bernheim J; Tepper R; Cordoba M; Beyth Y
Gynecol Obstet Invest; 1999; 48(3):187-92. PubMed ID: 10545744
[TBL] [Abstract][Full Text] [Related]
36. Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitors.
Garuti G; Cellani F; Centinaio G; Montanari G; Nalli G; Luerti M
Gynecol Oncol; 2006 Nov; 103(2):599-603. PubMed ID: 16750259
[TBL] [Abstract][Full Text] [Related]
37. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR
AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510
[TBL] [Abstract][Full Text] [Related]
38. Hysteroscopy for asymptomatic postmenopausal women with sonographically thickened endometrium.
Schmidt T; Breidenbach M; Nawroth F; Mallmann P; Beyer IM; Fleisch MC; Rein DT
Maturitas; 2009 Feb; 62(2):176-8. PubMed ID: 19121901
[TBL] [Abstract][Full Text] [Related]
39. [Use of hysteroscopy, ultrasonography and selected hormonal tests for diagnosis of hyperplastic endometrial changes].
Bedner R
Ann Acad Med Stetin; 2001; 47():89-105. PubMed ID: 12514904
[TBL] [Abstract][Full Text] [Related]
40. Hysteroscopy as a valid tool for endometrial pathology in patients with postmenopausal bleeding or asymptomatic patients with a thickened endometrium: hysteroscopic and histological results.
Loiacono RM; Trojano G; Del Gaudio N; Kardhashi A; Deliso MA; Falco G; Sforza R; Laera AF; Galise I; Trojano V
Gynecol Obstet Invest; 2015; 79(3):210-6. PubMed ID: 25765014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
